Imagion Biosystems Limited
IBXXF
$0.01
$0.00-10.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.50K | 15.50K | 8.20K | 8.10K | 335.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.50K | 15.50K | 8.20K | 8.10K | 335.60K |
| Cost of Revenue | 489.30K | 487.80K | 195.90K | 191.80K | 22.20K |
| Gross Profit | -473.80K | -472.30K | -187.70K | -183.80K | 313.40K |
| SG&A Expenses | 299.40K | 298.40K | 179.80K | 176.10K | 253.80K |
| Depreciation & Amortization | 1.40K | 1.40K | 1.40K | 1.40K | 2.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 790.10K | 787.60K | 377.10K | 369.30K | 278.60K |
| Operating Income | -774.60K | -772.10K | -368.90K | -361.20K | 57.00K |
| Income Before Tax | -869.00K | -866.20K | -532.20K | -521.10K | -176.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -869.00K | -866.20K | -532.20K | -521.10K | -176.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -869.00K | -866.20K | -532.20K | -521.10K | -176.00K |
| EBIT | -774.60K | -772.10K | -368.90K | -361.20K | 57.00K |
| EBITDA | -773.10K | -770.70K | -367.40K | -359.80K | 64.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 353.60M | 353.60M | 201.34M | 201.34M | 57.25M |
| Average Diluted Shares Outstanding | 353.60M | 353.60M | 201.34M | 201.34M | 57.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |